NDC 0002-4112-01 - Zyprexa

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0002-4112
Requested NDC: 0002-4112-01
Package NDCs from labels: 0002-4112-30, 0002-4112-01
Manufacturer: Eli Lilly and Company
Effective date: 2025-11-18
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Zyprexa - Eli Lilly and Company	Eli Lilly and Company	2025-11-18	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa	H.J. Harkins Company, Inc. \| Eli Lilly and Company \| Eli Lilly S.A. - Irish Branch \| Evonik Degussa Corporation \| Eli Lilly and Company (Indianapolis) \| Lilly del Caribe, Inc. (PR01) \| Patheon Italia S.p.A. \| Catalent UK Swindon ZYDIS LTD \| Catalent Pharma Solutions LLC - IL \| Sharp Corporation-Conshohocken	2011-10-25	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Dispensing Solutions, Inc.	Dispensing Solutions, Inc.	2011-10-04	HUMAN PRESCRIPTION DRUG LABEL
Zyprexa - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2009-11-30	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2012-07-24	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0002-4112-30	Zyprexa	30 in 1 BOTTLE	TABLET	30		67

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-4112	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	66	Legacy NDC, 1 package rows	20250110_d5051fbc-846b-4946-82df-341fb1216341.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-4112-01	EA - Each	0002-4112	af779e5a-fbbc-4bd3-90e0-d5e69f5e7cee	1	2012-07-24
0002-4112-04	EA - Each	0002-4112	56b11108-1b86-463c-9001-2ac77bf26271	1	2012-07-24
0002-4112-30	EA - Each	0002-4112	b214cae4-710a-4b89-94c5-930801920d26	1	2012-07-24
0002-4112-33	EA - Each	0002-4112	126f1982-9352-4445-b349-04ff9d337112	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Aspartame	INACTIVE INGREDIENT	Z0H242BBR1	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Gelatin	INACTIVE INGREDIENT	2G86QN327L	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Mannitol	INACTIVE INGREDIENT	3OWL53L36A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Methylparaben Sodium	INACTIVE INGREDIENT	CR6K9C2NHK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Polyethylene glycol 4000	INACTIVE INGREDIENT	4R4HFI6D95	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Propylparaben Sodium	INACTIVE INGREDIENT	625NNB0G9N	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Tartaric acid	INACTIVE INGREDIENT	W4888I119H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.]	1
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 27 of 114 · 2,276 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Drs. pharmacy sunscreen SPF 50 (physical filters)	SUNSCREEN SPF 50	OL PHARMA TECH LLC. (Drs. Pharmacy)	315a5ca4-4536-d585-e063-6294a90a1c50	2026-01-06	Warnings	Exact identifier unii: 15FIX9V2JP
Drs. pharmacy sunscreen SPF 30 (Physical Filters)	SUNSCREEN SPF 30	OL PHARMA TECH LLC. (Drs. Pharmacy)	315a5b1f-9dc2-a243-e063-6394a90a5e08	2026-01-06	Warnings	Exact identifier unii: 15FIX9V2JP
LING NEW YORK Save Face Broad Spectrum SPF 30	LING NEW YORK SAVE FACE BROAD SPECTRUM SPF 30	Guangzhou Fantesy Biotechnology Co.,Ltd	1dfa80bd-495a-18fb-e063-6394a90a4d0d	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO UV PROTECTIVE FOUNDATION FAIR IVORY	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	236bdb53-d7a5-43a2-8a0c-bce4a5522e26	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
cle de peau BEAUTE RADIANT FOUNDATION N I10	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	05ffb157-5e28-4e94-866d-9e3371480d84	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
cle de peau BEAUTE CONCEALER N 1	TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	eedf8065-8897-4773-9cbb-bab57d2dd04f	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
cle de peau BEAUTE BRIGHTENING ENHANCER VEIL	OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	bb00d6d7-cc51-4fee-a0df-68bbd5bc50d6	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
cle de peau BEAUTE THE FOUNDATION N I10 VERY LIGHT IVORY	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	beefe840-6f32-483b-8a37-2696adb8eea1	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO SPORTS BB LIGHT	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	260a3eab-8fe6-4259-8dcc-3706ca1f6881	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO ULTIMATE SUN PROTECTOR	OCTISALATE, TITANIUM DIOXIDE, OCTOCRYLENE, AND ZINC OXIDE	SHISEIDO AMERICAS CORPORATION	c656792a-e1ed-478d-b501-9bdc92d16eca	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 110 ALABASTER	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	0a214b6b-69a7-4cb9-9095-6fcf2b6945de	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 430 CEDAR	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	fb6ac681-ff74-4420-a4f6-843d5f2b6d6b	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
Hawaiian Blend Essential Zinc SPF 50	ZINC OXIDE, TITANIUM DIOXIDE	The Islander Group	47aa8605-e536-b998-e063-6394a90ad9f0	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO WHITE LUCENT ONMAKEUP SPOT CORRECTING SERUM NATURAL LIGHT	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	bf736c5b-fc33-4cd5-8d18-03929f739d76	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
CLE DE PEAU BEAUTE RADIANT CORRECTOR FOR EYES IVORY	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	c4028089-677f-4d51-9c8b-3892ff1649e0	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION 110	OCTINOXATE AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	8a0da327-a805-4ef9-b69a-14bf7278a81a	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
CLE DE PEAU BEAUTE CORRECTING VEIL n	ENSULIZOLE, OCTINOXATE, AND TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	fd9b42e4-6f9d-45a9-bee3-ac1bc4b35252	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
SHISEIDO THE MAKEUP FOUNDATION I20	TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	3c024fe9-2983-4857-a55a-13406158e3a9	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
cle de peau BEAUTE RADIANT FLUID FOUNDATION BF10	TITANIUM DIOXIDE	SHISEIDO AMERICAS CORPORATION	b2b55a7a-1f68-429d-ba70-5bb6c7e0d8d3	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP
TRICK AND TREAT CC2 - Active Moisturizing Color Correcting Broad-Spectrum SPF 46 Plus	TITANIUM DIOXIDE	HEY HONEY INC.	21187805-fae9-476c-81b0-27ffeb0b9911	2026-01-05	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.